DNA damage, superoxide, and mutant K-ras in human lung adenocarcinoma cells

Free Radical Biology and Medicine

Volumn 43, Issue 8, 2007, Pages 1145-1155

  Romanowska, Malgorzata ^a   Maciag, Anna ^a   Smith, Andrew L ^a   Fields, Janet R ^a   Fornwald, Laura W ^b   Kikawa, Keith D ^a   Kasprzak, Kazimierz S ^a   Anderson, Lucy M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Comet assay; DNA damage; Human lung adenocarcinoma; K ras; Manganese superoxide dismutase; OGG1; Reactive oxygen species; Single strand breaks; Superoxide

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; K RAS PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ADULT; ARTICLE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DNA STRAND BREAKAGE; FEMALE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MALE; MUTATION; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADENOCARCINOMA; CELL LINE, TUMOR; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR ENZYMES; GENES, RAS; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; PHOSPHORIC MONOESTER HYDROLASES; RAS PROTEINS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 34548543291     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.07.004     Document Type: Article

References (53)

1. Chang J.W., Chen Y.C., Chen C.Y., Chen J.T., Chen S.K., and Wang Y.C. Correlation of genetic instability with mismatch repair protein expression and p53 mutations in non-small cell lung cancer. Clin. Cancer Res. 6 (2000) 1639-1646
2. Shridhar V., Siegfried J., Hunt J., del Mar Alonso M., and Smith D.I. Genetic instability of microsatellite sequences in many non-small cell lung carcinomas. Cancer Res. 54 (1994) 2084-2087
3. Hittelman W.N. Genetic instability in epithelial tissues at risk for cancer. Ann. N. Y. Acad. Sci. 952 (2001) 1-12
4. Colleu-Durel S., Guitton N., Nourgalieva K., Legue F., Leveque J., Danic B., and Chenal C. Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur. J. Cancer 40 (2004) 445-451
5. Maciag A., and Anderson L.M. Reactive oxygen species and lung tumorigenesis by mutant K-ras: a working hypothesis. Exp. Lung Res. 31 (2005) 83-104
6. Phelps R.M., Johnson B.E., Ihde D.C., Gazdar A.F., Carbone D.P., McClintock P.R., Linnoila R.I., Matthews M.J., Bunn P.A., Carney D., Minna J.D., and Mulshine J.L. NCI-Navy Medical Oncology Branch cell line data base. J. Cell. Biochem., Suppl. 24 (1996) 32-91
7. Masuda A., Kondo M., Saito T., Yatabe Y., Kobayashi T., Okamoto M., Suyama M., Takahashi T., and Takahashi T. Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor β1. Cancer Res. 57 (1997) 4898-4904
8. Kammouni W., Ramakrishna G., Sithanandam G., Smith G.T., Fornwald L.W., Masuda A., Takahashi T., and Anderson L.M. Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence. Cell Growth Diff. 13 (2002) 441-448
9. V12 increases COX-2, peroxides and DNA damage in lung cells. Carcinogenesis 25 (2004) 2231-2237
10. Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
11. Rook G.A., Steele J., Umar S., and Dockrell H.M. A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J. Immunol. Methods 82 (1985) 161-167
12. Wu X., Roth J.A., Zhao H., Luo S., Zheng Y.L., Chiang S., and Spitz M.R. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 65 (2005) 349-357
13. Roper J.M., Mazzatti D.J., Watkins R.H., Maniscalco W.M., Keng P.C., and O'Reilly M.A. In vivo exposure to hyperoxia induces DNA damage in a population of alveolar type II epithelial cells. Am. J. Physiol.: Lung Cell. Mol. Physiol. 286 (2004) L1045-L1054
14. Panayiotidis M.I., Rancourt R.C., Allen C.B., Riddle S.R., Schneider B.K., Ahmad S., and White C.W. Hyperoxia-induced DNA damage causes decreased DNA methylation in human lung epithelial-like A549 cells. Antioxid. Redox Signal. 6 (2004) 129-136
15. Osterod M., Larsen E., Le Page F., Hengstler J.G., Van Der Horst G.T.J., Boiteux S., Klungland A., and Epe B. A global DNA repair mechanism involving the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation of endogenous oxidative DNA base damage. Oncogene 21 (2002) 8232-8239
16. Nishimura S. Involvement of mammalian OGG1 (MMH) in excision of the 8-hydroxyguanine residue in DNA. Free Radic. Biol. Med. 32 (2002) 813-821
17. Arai T., Kelly V.P., Komoro K., Minowa O., Noda T., and Nishimura S. Cell proliferation in liver of Mmh/Ogg1-deficient mice enhances mutation frequency because of the presence of 8-hydroxyguanine in DNA. Cancer Res. 63 (2003) 4287-4292
18. Xie Y., Yang H., Cunanan C., Okamoto K., Shibata D., Pan J., Barnes D.E., Lindahl T., McIlhatton M., Fishel R., and Miller J.H. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res. 64 (2004) 3096-3102
19. Russo M.T., De Luca G., Degan P., Parlanti E., Dogliotti E., Barnes D.E., Lindahl T., Yang H., Miller J.H., and Bignami M. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res. 64 (2004) 4411-4414
20. Paz-Elizur T., Krupsky M., Blumenstein S., Elinger D., Schechtman E., and Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J. Natl. Cancer Inst. 95 (2003) 1312-1319
21. Lan Q., Mumford J.L., Shen M., Demarini D.M., Bonner M.R., He X., Yeager M., Welch R., Chanock S., Tian L., Chapman R.S., Zheng T., Keohavong P., Caporaso N., and Rothman N. Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 25 (2004) 2177-2181
22. Hung R.J., Hall J., Brennan P., and Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 162 (2005) 925-942
23. Zienolddiny S., Campa D., Lind H., Ryberg D., Skaug V., Stangeland L., Phillips D.H., Canzian F., and Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27 (2006) 560-567
24. Kohno T., Kunitoh H., Toyama H., Yamamoto S., Kuchiba A., Saito D., Yanagitani N., Ishihara S.I., Saito R., and Yokota J. Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci. 97 (2006) 724-728
25. Tsuzuki T., Egashira A., Igarashi H., Iwakuma T., Nakatsuru Y., Tominaga Y., Kawate H., Nakao K., Nakamura K., Ide F., Kura S., Nakabeppu Y., Katsuki M., Ishikawa T., and Sekiguchi M. Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11456-11461
26. Sekiguchi M., and Tsuzuki T. Oxidative nucleotide damage: consequences and prevention. Oncogene 21 (2002) 8895-8904
27. Sakumi K., Tominaga Y., Furuichi M., Xu P., Tsuzuki T., Sekiguchi M., and Nakabeppu Y. Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res. 63 (2003) 902-905
28. Kennedy C.H., Cueto R., Belinsky S.A., Lechner J.F., and Pryor W.A. Overexpression of hMTH1 mRNA: a molecular marker of oxidative stress in lung cancer cells. FEBS Lett. 429 (1998) 17-20
29. Kennedy C.H., Pass H.I., and Mitchell J.B. Expression of human MutT homologue (hMTH1) protein in primary non-small-cell lung carcinomas and histologically normal surrounding tissue. Free Radic. Biol. Med. 34 (2003) 1447-1457
30. Speina E., Arczewska K.D., Gackowski D., Zielinska M., Siomek A., Kowalewski J., Olinski R., Tudek B., and Kusmierek J.T. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients. J. Natl. Cancer Inst. 97 (2005) 384-395
31. Svensk A.M., Soini Y., Paakko P., Hiravikoski P., and Kinnula V.L. Differential expression of superoxide dismutases in lung cancer. Am. J. Clin. Pathol. 122 (2004) 395-404
32. Wang L.I., Miller D.P., Sai Y., Liu G., Su L., Wain J.C., Lynch T.J., and Christiani D.C. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J. Natl. Cancer Inst. 93 (2001) 1818-1821
33. Liu G., Zhou W., Park S., Wang L.I., Miller D.P., Wain J.C., Lynch T.J., Su L., and Christiani D.C. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms. Cancer 101 (2004) 2802-2808
34. Kinnula V.L., and Crapo J.D. Superoxide dismutases in malignant cells and human tumors. Free Radic. Biol. Med. 36 (2004) 718-744
35. Sundaresan M., Yu Z.X., Ferrans V.J., Sulciner D.J., Gutkind J.S., Irani K., Goldschmidt-Clermont P.J., and Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318 (1996) 379-382
36. Irani K., Xia Y., Zweier J.L., Sollot S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., and Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275 (1997) 1649-1652
37. Liou J.S., Chen Y., Chen J.S., and Faller D.V. Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. J. Biol. Chem. 275 (2000) 39001-39011
38. Cho H.J., Jeong H.G., Lee J.S., Woo E.R., Hyun J.W., Chung M.H., and You H.J. Oncogenic H-ras enhances DNA repair through the Ras/phosphatidylinositol 3-kinase/Rac1 pathway in NIH3T3 cells. Evidence for association with reactive oxygen species. J. Biol. Chem. 277 (2002) 19358-19366
39. Liu R., Li B., and Qui M. Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-α. Oncogene 20 (2001) 1486-1496
40. Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., Yu Z.X., Ferrans V.J., Howard B.H., and Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274 (1999) 7936-7940
41. Yang J.Q., Li S., Domann F.E., Buettner G.R., and Oberley L.W. Superoxide generation in v-Ha-ras-transfected human keratinocyte HaCaT cells. Mol. Carcinog. 26 (1999) 180-188
42. Yang J.Q., Li S., Huang Y., Zhang H.J., Domann F.E., Buettner G.R., and Oberley L.W. V-Ha-ras overexpression induces superoxide production and alters levels of primary antioxidant enzymes. Antioxid. Redox Signal. 3 (2001) 697-709
43. Rosell R., Li S., Skacel Z., Mate J.L., Maestre J., Canela M., Tolosa E., Armengol P., Barnadas A., and Ariza A. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene 8 (1993) 2407-2412
44. Al-Mulla F., Going J.J., Sowden E.T., Winter A., Pickford I.R., and Birnie G.D. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J. Pathol. 185 (1998) 130-138
45. Al-Mulla F., Milner-White E.J., Going J.J., and Birnie G.D. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression. J. Pathol. 187 (1999) 433-438
46. Corominas M., Perucho M., Newcomb E.W., and Pellicer A. Differential expression of the normal and mutated K-ras alleles in chemically induced thymic lymphomas. Cancer Res. 51 (1991) 5129-5133
47. Hanson L.A., Nuzum E.O., Jones B.C., Malkinson A.M., and Beer D.G. Expression of the glucocorticoid receptor and K-ras genes in urethan-induced mouse lung tumors and transformed cell lines. Exp. Lung Res. 17 (1991) 371-387
48. Pan Y.H., Nuzum E.O., Hanson L.A., and Beer D.G. Ki-ras activation and expression in transformed mouse lung cell lines. Mol. Carcinog. 3 (1990) 279-286
49. Jones-Bolin S.E., Johansson E., Palmisano W.A., Anderson M.W., Wiest J.S., and Belinsky S.A. Effect of promoter and intron 2 polymorphisms on murine lung K-ras gene expression. Carcinogenesis 19 (1998) 1503-1508
50. Mammas I.N., Zafiropoulos A., Koumantakis E., Sifakis S., and Spandidos D.A. Transcriptional activation of H- and N-ras oncogenes in human cervical cancer. Gynecol. Oncol. 92 (2004) 941-948
51. Uchiyama M., Usami N., Kondo M., Mori S., Ito M., Ito G., Yoshioka H., Imaizumi M., Ueda Y., Takahashi M., Minna J.D., Shimokata K., and Sekido Y. Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer. Int. J. Cancer 107 (2003) 962-969
52. Cullen J.J., Weydert C., Hinkhouse M.S., Ritchie J., Domann F.E., Spitz D., and Oberley L.W. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res. 63 (2003) 1297-1303
53. Walsh A.B., and Bar-Sagi D. Differential activation of the Rac pathway by Ha-ras and K-ras. J. Biol. Chem. 276 (2001) 15609-15615